Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphoma

15 Jul 2019

Abstract excerpt

There has been growing interest in using circulating-tumor DNA (ctDNA) to diagnose brain tumors including malignant lymphomas [1,2]. About 85% of primary central nervous system lymphoma (PCNSL) cas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to CNS Lymphoma Diagnosis and Treatment
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31305194
DOI: 10.1080/10428194.2019.1639169

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphomaPMID 31305194Read ↗

The emerging role of circulating tumor DNA in brain tumor researchSemantic proximity Read ↗

Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma.Semantic proximity Read ↗

Detection of genes mutations in cerebrospinal fluid circulating tumor DNA from central nervous system lymphomas patients using next generation sequencingSemantic proximity Read ↗

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasmaSemantic proximity Read ↗

Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients' management: Close to the clinic?Semantic proximity Read ↗

The “Liquid Biopsy”: the Role of Circulating DNA and RNA in Central Nervous System TumorsSemantic proximity Read ↗

Improvements in Quality Control and Library Preparation for Targeted Sequencing Allowed Detection of Potentially Pathogenic Alterations in Circulating Cell-Free DNA Derived from Plasma of Brain Tumor PatientsSemantic proximity Read ↗

Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.Semantic proximity Read ↗

Circulating tumor DNA as a powerful tool in diagnostics and treatment outcome prediction - focus on large B-cell lymphomas and follicular lymphomas.Semantic proximity Read ↗

Current Role and Future Potential of CSF ctDNA for the Diagnosis and Clinical Management of Pediatric Central Nervous System Tumors.Semantic proximity Read ↗

[Progression and application of circulating tumor DNA in lymphoma].Semantic proximity Read ↗

Clinical use of circulating tumor DNA analysis in patients with lymphomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.